Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial.
Ikeda M, Kudo M, Aikata H, Nagamatsu H, Ishii H, Yokosuka O, Torimura T, Morimoto M, Ikeda K, Kumada H, Sato T, Kawai I, Yamashita T, Horio H, Okusaka T; Miriplatin TACE Study Group.
Ikeda M, et al. Among authors: ikeda k.
J Gastroenterol. 2018 Feb;53(2):281-290. doi: 10.1007/s00535-017-1374-6. Epub 2017 Aug 1.
J Gastroenterol. 2018.
PMID: 28766016
Free PMC article.
Clinical Trial.